The trial will evaluate a single CTC analysis pipeline that incorporates cell enumeration and isolation systems from Menarini-Silicon Biosystems.
The study, launched today, aims to evaluate the use of liquid biopsy and natural killer cell testing for the early detection of recurrent breast cancer.
A Complete Genomics-led team isolated and sequenced the genomes of 34 circulating tumor cells from a woman with metastatic breast cancer.
VWR will act as the exclusive distributor for Biocept's liquid biopsy blood collection tubes everywhere in the world except China.
Asia Genomics will make CellMax's tests, including the CellMax-DNA Genetic Cancer Risk Test Assure and the CellMax-CRC Protect Test, available immediately.
New research has identified circulating cell subtypes with ties to better or worse outcomes in individuals with prostate cancer.
The company intends to use the funds to automate its platform and internationally commercialize its colorectal cancer detection assay.
While Cynvenio will still perform testing in its own lab right now, the firm's CEO said that interested labs could move the technology in house in the future if they desire.
The company also received a grant from the Maryland Innovation Initiative to help advance the device toward commercialization.
New data points to strong predictive ability for a ddPCR-based test of AR copy number, while other companies are pursuing tests that target expression of AR splice variants.
Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.
Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.
China is embracing preimplantation genetic diagnosis, Nature News reports.
In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.